Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blumenthal

Showing results (601-610 of 650) with videos related to

Pageof 65
Sort By:
Biorxiv : the Preprint Server for Biology|April 15, 2024
Quinoline-based compounds can inhibit diverse enzymes that act on DNAJujun Zhou, Qin Chen, Ren Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2024
Naturalized species drive functional trait shifts in plant communitiesMagda Garbowski, Daniel C Laughlin, Dana M Blumenthal, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2026
Regulation of BCL11A DNA binding and expression in human erythrocyte precursor HUDEP-2 cellsMeigen Yu, Puspa Das, John R Horton, et al.
The New Phytologist|June 24, 2025
Why are non-native plants successful? Consistently fast economic traits and novel origin jointly explain abundance across US ecoregionsDana M Blumenthal, Jeffrey Diez, Ian Pearse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmEmily Y Jen, Xin Gao, Liang Li, et al.
The Lancet. Oncology|January 24, 2018
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysisJulia A Beaver, Maitreyee Hazarika, Flora Mulkey, et al.
Clinical Pharmacology and Therapeutics|February 24, 2018
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a DiseaseRobert N Schuck, Janet Woodcock, Issam Zineh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Clinical Development of Novel Drug-Radiotherapy CombinationsSaif S Ahmad, Marka R Crittenden, Phuoc T Tran, et al.
Oncotarget|October 21, 2014
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsGideon M Blumenthal, Joell J Gills, Marc S Ballas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2021
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level AnalysesKelly J Norsworthy, Xin Gao, Chia-Wen Ko, et al.
Pageof 65

Showing results (601-610 of 650) with videos related to

Sort By:
Pageof 65
Biorxiv : the Preprint Server for Biology|April 15, 2024
Quinoline-based compounds can inhibit diverse enzymes that act on DNAJujun Zhou, Qin Chen, Ren Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2024
Naturalized species drive functional trait shifts in plant communitiesMagda Garbowski, Daniel C Laughlin, Dana M Blumenthal, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2026
Regulation of BCL11A DNA binding and expression in human erythrocyte precursor HUDEP-2 cellsMeigen Yu, Puspa Das, John R Horton, et al.
The New Phytologist|June 24, 2025
Why are non-native plants successful? Consistently fast economic traits and novel origin jointly explain abundance across US ecoregionsDana M Blumenthal, Jeffrey Diez, Ian Pearse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmEmily Y Jen, Xin Gao, Liang Li, et al.
The Lancet. Oncology|January 24, 2018
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysisJulia A Beaver, Maitreyee Hazarika, Flora Mulkey, et al.
Clinical Pharmacology and Therapeutics|February 24, 2018
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a DiseaseRobert N Schuck, Janet Woodcock, Issam Zineh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Clinical Development of Novel Drug-Radiotherapy CombinationsSaif S Ahmad, Marka R Crittenden, Phuoc T Tran, et al.
Oncotarget|October 21, 2014
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsGideon M Blumenthal, Joell J Gills, Marc S Ballas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2021
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level AnalysesKelly J Norsworthy, Xin Gao, Chia-Wen Ko, et al.
Pageof 65